Basics Tango Therapeutics, Inc. IPO Date: September 3, 2020 Sector: Healthcare Industry: Biotech Market Cap: $772.15M Activated in VL: True Average Daily Range Avg Daily Range: $0.24 | 3.81% Avg Daily Range (30 D): $0.19 | 2.86% Avg Daily Range (90 D): $0.19 | 5.28% Institutional Daily Volume Avg Daily Volume: .69M Avg Daily Volume (30 D): 1.54M Avg Daily Volume (90 D): 2.24M Trade Size Avg Trade Size (Sh.): 111 Avg Trade Size (Sh.) (30 D): 114 Avg Trade Size (Sh.) (90 D): 139 Institutional Trades Total Inst.Trades: 633 Avg Inst. Trade: $1.57M Avg Inst. Trade (30 D): $1.09M Avg Inst. Trade (90 D): $1.33M Avg Inst. Trade Volume: .22M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.45M Avg Closing Trade (30 D): $.75M Avg Closing Trade (90 D): $1.14M Avg Closing Volume: 196.72K     News Aug 26, 2025 @ 11:00 AM Tango Therapeutics to Participate in the 2025 Cant... Source: Barbara Weber, M.D. Aug 6, 2025 @ 12:25 AM Tango (TNGX) Q2 Revenue Drops 52% Source: Na Jun 27, 2025 @ 11:00 AM Tango Therapeutics Announces First Patient Dosed i... Source: Tango Therapeutics May 27, 2025 @ 11:00 AM Tango Therapeutics to Participate in the 46th Annu... Source: N/A May 12, 2025 @ 11:00 AM Tango Therapeutics Reports First Quarter 2025 Fina... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.32 $-.35 $-.36 Diluted EPS $-1.32 $-.35 $-.36 Revenue $ 24.3M $ 3.18M $ 5.39M Gross Profit $ $ $ Net Income / Loss $ -145.57M $ -38.85M $ -39.88M Operating Income / Loss $ -157.29M $ -40.97M $ -42.53M Cost of Revenue $ $ $ Net Cash Flow $ -12.29M $ -19.16M $ -11.1M PE Ratio